Laurus Labs' Stock Sees -3.35% Decline, MarketsMOJO Gives 'Hold' Call

Laurus Labs, a leading pharmaceutical company in the largecap industry, saw a decline of -3.35% in its stock price on October 4th, 2024. This underperformance was noted by MarketsMOJO, who have given a 'Hold' call for the stock.

The stock has been on a downward trend for the past two days, with a fall of -4.7% during this period. On October 4th, the stock touched an intraday low of Rs 443.4, a decrease of -3.68%. While the stock's performance is higher than its 200 day moving average, it is lower than its 5 day, 20 day, 50 day, and 100 day moving averages.

In comparison to the Sensex, Laurus Labs' performance on October 4th was -3.27%, while the Sensex's performance was -0.90%. Over the past month, Laurus Labs' stock has seen a decline of -6.58%, while the Sensex has only seen a decline of -0.73%.

Despite the recent decline in stock price, Laurus Labs remains a strong player in the pharmaceutical industry. Investors should keep an eye on the company's performance in the coming days, as it may present a good buying opportunity. However, it is important to note that this article is based on facts and does not offer any recommendations or mention any potential future growth.